OBJECTIVE: The hypothesis that daily use of a prenatal supplement with iron from enrollment to third trimester to initially iron-replete, nonanemic pregnant women would reduce third-trimester anemia and improve birth outcomes was tested. STUDY DESIGN:Eight hundred sixty-seven women in Raleigh, North Carolina, who were at < 20 weeks of gestation were enrolled; 429 of these women had hemoglobin levels of > or = 110 g/L and ferritin levels of > or = 40 microg/L and were assigned randomly to receive prenatal supplements with 30 mg of iron as ferrous sulfate (n = 218 women) or 0 mg of iron (n = 211 women) until 26 to 29 weeks of gestation. Intent-to-treat analysis was used for the outcomes of third-trimester iron status, birth weight, preterm birth, and small-for-gestational age. RESULTS:Mean birth weight was higher by 108 g (P = .03), and the incidence of preterm delivery was lower (8% vs 14%; P = .05) in the 30-mg group compared with the control group, respectively. Iron supplementation did not affect the prevalence of small-for-gestational age infants or third-trimester iron status. CONCLUSION:Prophylactic iron supplementation that is begun early in pregnancy among low income women in the United States may have benefits beyond the reduction of iron deficiency anemia during pregnancy.
RCT Entities:
OBJECTIVE: The hypothesis that daily use of a prenatal supplement with iron from enrollment to third trimester to initially iron-replete, nonanemic pregnant women would reduce third-trimester anemia and improve birth outcomes was tested. STUDY DESIGN: Eight hundred sixty-seven women in Raleigh, North Carolina, who were at < 20 weeks of gestation were enrolled; 429 of these women had hemoglobin levels of > or = 110 g/L and ferritin levels of > or = 40 microg/L and were assigned randomly to receive prenatal supplements with 30 mg of iron as ferrous sulfate (n = 218 women) or 0 mg of iron (n = 211 women) until 26 to 29 weeks of gestation. Intent-to-treat analysis was used for the outcomes of third-trimester iron status, birth weight, preterm birth, and small-for-gestational age. RESULTS: Mean birth weight was higher by 108 g (P = .03), and the incidence of preterm delivery was lower (8% vs 14%; P = .05) in the 30-mg group compared with the control group, respectively. Iron supplementation did not affect the prevalence of small-for-gestational age infants or third-trimester iron status. CONCLUSION: Prophylactic iron supplementation that is begun early in pregnancy among low income women in the United States may have benefits beyond the reduction of iron deficiency anemia during pregnancy.
Authors: A Z Khambalia; C E Collins; C L Roberts; J M Morris; K L Powell; V Tasevski; N Nassar Journal: Eur J Clin Nutr Date: 2015-09-16 Impact factor: 4.016
Authors: Christiana R Titaley; Michael J Dibley; Christine L Roberts; John Hall; Kingsley Agho Journal: Bull World Health Organ Date: 2009-12-29 Impact factor: 9.408
Authors: Parul Christian; Christine P Stewart; Steven C LeClerq; Lee Wu; Joanne Katz; Keith P West; Subarna K Khatry Journal: Am J Epidemiol Date: 2009-09-24 Impact factor: 4.897
Authors: Analee J Etheredge; Zul Premji; Nilupa S Gunaratna; Ajibola Ibraheem Abioye; Said Aboud; Christopher Duggan; Robert Mongi; Laura Meloney; Donna Spiegelman; Drucilla Roberts; Davidson H Hamer; Wafaie W Fawzi Journal: JAMA Pediatr Date: 2015-10 Impact factor: 16.193
Authors: Vanessa A Fitsanakis; Kimberly N Thompson; Sarah E Deery; Dejan Milatovic; Zak K Shihabi; Keith M Erikson; Russell W Brown; Michael Aschner Journal: Neurotox Res Date: 2009-02-21 Impact factor: 3.911